These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38787982)

  • 1. Analysis of correlative factors of female coronary slow-flow phenomenon: A retrospective study.
    Chen X; Zhang A; Xu Z; Yin Z; Wang C; Zhang J; Bian L
    Medicine (Baltimore); 2024 May; 103(21):e38262. PubMed ID: 38787982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics in patients with coronary slow flow phenomenon: A retrospective study.
    Huang Q; Zhang F; Chen S; Dong Z; Liu W; Zhou X
    Medicine (Baltimore); 2021 Feb; 100(6):e24643. PubMed ID: 33578588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: A single centre experience.
    Sanghvi S; Mathur R; Baroopal A; Kumar A
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S290-S294. PubMed ID: 30595277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.
    Zhang XJ; Hou AJ; Luan B; Wang CF; Li JJ
    BMC Cardiovasc Disord; 2024 Jul; 24(1):358. PubMed ID: 39003493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory predictors of coronary slow flow in coronary angiography.
    Ghaffari S; Tajlil A; Aslanabadi N; Separham A; Sohrabi B; Saeidi G; Pourafkari L
    Perfusion; 2017 Jan; 32(1):13-19. PubMed ID: 27412375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary slow flow--prevalence and clinical correlations.
    Hawkins BM; Stavrakis S; Rousan TA; Abu-Fadel M; Schechter E
    Circ J; 2012; 76(4):936-42. PubMed ID: 22293446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic and laboratory findings in coronary slow flow phenomenon: cross-sectional study and review.
    Seyyed Mohammadzad MH; Khademvatani K; Gardeshkhah S; Sedokani A
    BMC Cardiovasc Disord; 2021 May; 21(1):230. PubMed ID: 33952204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of coronary slow flow on left atrial structure and function.
    Shui Z; Wang Y; Sun M; Gao Y; Liang S; Wang Y; Wang X; Yu Q; Zhang S; Liu L
    Sci Rep; 2021 Apr; 11(1):7511. PubMed ID: 33820937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between coronary slow flow phenomenon and coronary calcium score.
    Oz O; Bayram NA; Durmaz T; Keles T; Akcay M; Bozkurt E
    Perfusion; 2010 Mar; 25(2):97-102. PubMed ID: 20427414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Interleukin-1 Gene cluster polymorphisms with coronary slow flow phenomenon.
    Mutluer FO; Ural D; Güngör B; Bolca O; Aksu T
    Anatol J Cardiol; 2018 Jan; 19(1):34-41. PubMed ID: 29339698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?
    Kaplangoray M; Toprak K; Deveci E; Caglayan C; Şahin E
    Cardiovasc Toxicol; 2024 May; 24(5):519-526. PubMed ID: 38622332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between pan-immune-inflammation value and coronary slow flow phenomenon in patients with angiographically normal coronary arteries.
    Akkaya S; Cakmak U
    Int J Cardiol; 2024 Mar; 398():131631. PubMed ID: 38048881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study.
    Xin Y; Zhang J; Fan Y; Wang C
    BMC Cardiovasc Disord; 2021 Jul; 21(1):343. PubMed ID: 34266394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon.
    Wang Y; Liu MJ; Yang HM; Ma CY; Jia PY; Jia DL; Hou AJ
    BMC Cardiovasc Disord; 2018 Jul; 18(1):138. PubMed ID: 29973151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Primary Coronary Slow-Flow Phenomenon and Epicardial Fat Tissue.
    Weferling M; Vietheer J; Keller T; Fischer-Rasokat U; Hamm CW; Liebetrau C
    J Invasive Cardiol; 2021 Jan; 33(1):E59-E64. PubMed ID: 33385988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric Dimethylarginine Is Associated with the Phenomenon of Coronary Slow Flow in Patients with Nonvalvular Atrial Fibrillation.
    Du Z; Jiang W; Yu C; Lu X; Xia W
    Cardiology; 2024; 149(3):208-216. PubMed ID: 38246155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility Study of Transthoracic Echocardiography for Coronary Slow Flow Phenomenon Evaluation: Validation by Coronary Angiography.
    Li Y; Fang F; Ma N; Li R; Sun Q; Yang J; Nie S; Yu CM; Yang Y
    Microcirculation; 2016 May; 23(4):277-82. PubMed ID: 26991324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary slow-flow phenomenon.
    Aciksari G; Cetinkal G; Kocak M; Atici A; Celik FB; Caliskan M
    Int J Cardiovasc Imaging; 2022 Jan; 38(1):5-13. PubMed ID: 34453654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial elasticity in obese subjects with coronary slow flow phenomenon.
    Hussein O; Zidan J; Plich M; Gefen H; Klein R; Shestatski K; Abu-Jabal K; Zimlichman R
    Isr Med Assoc J; 2013 Dec; 15(12):753-7. PubMed ID: 24449979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase reactants in patients with coronary slow flow phenomenon.
    Madak N; Nazlı Y; Mergen H; Aysel S; Kandaz M; Yanık E; Cekdemir D; Tavlı T
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):416-20. PubMed ID: 20929698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.